MacleanN., ed. (1995). Animals With Novel Genes, 282 pp. Cambridge, UK: Cambridge University Press.
3.
GordonJ.W. (1996). Transgenic technology and its impact on laboratory animal science.Scandinavian Journal of Laboratory Animal Science23, 235–249.
4.
BeardmoreJ.A. (1997). Transgenics, autotransgenics and allotransgenics.Transgenics Research6, 107–108.
5.
Anon. (1997). Statistics of Scientific Procedures on Living Animals — Great Britain, 1996, Cm 3722, p. 30. London: HMSO.
6.
HubrechtR. (1995). Genetically modified animals, welfare and UK legislation.Animal Welfare4, 163–170.
7.
MooreC.J., and MephamT.B. (1995). Transgenesis and animal welfare.ATLA23, 380–397.
8.
van ZutphenL.F.M., & van der MeerM. eds (1997). Welfare Aspects of Transgenic Animals, 119 pp. Berlin: Springer-Verlag.
9.
PooleT. (1997). Transgenic animals: an alternative? Opponent's statement. In Developments in Animal and Veterinary Sciences, Vol. 27, Animal Alternatives, Welfare and Ethics (ed. van ZutphenL.F.M., & BallsM.), pp. 267–272. Amsterdam: Elsevier.
10.
Anon. (1997). Guidelines on Transgenic Animals, 9 pp. Ottawa, Canada.: CCAC.
11.
TomizukaK., YoshidaH., UejimiH., KugohH., SatoK., OhgumaA., HayasakaM., HanaokaK., OshimuraM., and IshidaI. (1997). Functional expression and germline transmission of a human chromosome fragment in chimaeric mice.Nature Genetics16, 133–143.
12.
Anon. (1997). Europe ambivalent on biotechnology.Nature387, 845–847.
13.
SandoeP., ForsmanB., and HansenA.K. (1996). Transgenic animals: the need for ethical dialogue.Scandinavian Journal of Laboratory Animal Science23, 279–285.
14.
Anon. (1996). Group of Advisers to the European Commission on the Ethical Implications of Biotechnology, 24 pp. Luxembourg: Office for the Official Publications of the European Communities.
15.
BallsM., GoldbergA.M., FentemJ.H., Broad-headC.L., BurchR.L., FestingM.F.W., FrazierJ.M., HendriksenC.F.M., JenningsM., van der KampM.D.O., MortonD.B., RowanA.N., RussellC., RussellW.M.S., SpielmannH., StephensM.L., StokesW.S., StraughanD.W., YagerJ.D., ZurloJ., & van ZutphenB.F.M. (1995). The Three Rs: the way forward. The report and recommendations of ECVAM workshop 11.ATLA23, 838–866.
16.
BedellM.A., LargaespadaD.A., JenkinsN.A., and CopelandN.G. (1997). Mouse models of human disease. II. Recent progress and future directions.Genes and Development11, 11–43.
17.
WoychickR.P., WassomJ.S., and KingsburyD. (1993). TBASE: a computerized database for transgenic animals and targeted mutations.Nature363, 375–376.
18.
DorinJ.R., DickinsonP., AltonE.W.F.W., SmithS.N., GeddesD.M., StevensonB.J., KimberW.L., FlemingS., ClarkeA.R., HooperM.L., AndersonL., BeddingtonR.S.P., and PorteousD.J. (1992). Cystic fibrosis in the mouse by targeted insertional mutagenesis.Nature359, 211–215.
19.
ForsterR. (1995). Measuring genetic events in transgenic animals. In Environmental Mutagenesis (ed. PhillipsD.H., VenittS.), pp. 291–314. Oxford, UK: Bios Scientific Publishers.
20.
GorelickN.J. (1995). Overview of mutation assays in transgenic mice for routine testing.Environmental and Molecular Mutagenesis25, 218–230.
21.
SuzukiT., HayashiM., SofuniT., and MyhrB.C. (1993). The concomitant detection of gene mutation and micronucleus induction by mitomycin C in vivo using lac Z transgenic mice.Mutation Research285, 219–224.
22.
GossenJ.A., MartusH-J., WeiJ.Y., and VijgJ. (1995). Spontaneous and X-ray induced deletion mutations in a lac Z plasmid-based transgenic mouse model.Mutation Research331, 89–97.
23.
HasemanJ.K., and LockhardtA. (1994). The relationship between the use of the maximum tolerated dose and study sensitivity for detecting rodent carcinogenicity.Fundamental and Applied Toxicology22, 382–391.
24.
KroeseE.D., van SteegH., van OostromC.T., DortantP.M., WesterP., van KranenH.J., de VriesA., & van KreijlC.F. (1997). Use of E-pim transgenic mice for short-term in vivo carcinogenicity testing: lymphoma induction by benzo[a]pyrene but not TPA.Carcinogenesis19, 975–980.
25.
TennantR.W., FrenchJ.E., and SpaldingJ.W. (1995). Identifying chemical carcinogens and assessing potential risks in short-term bioassays using transgenic mouse models.Environmental Health Perspectives103, 942–950.
26.
YamamotoS. (1996). Rapid induction of more malignant tumours by various genotoxic carcinogens in transgenic mice harbouring human proto-type c-H-ras gene than in control non-transgenic mice.Carcinogenesis17, 2455–2461.
27.
De VriesA., van OostromC.T.M., DortantP.M., BeemsR.B., van KreijlC.F., CapelP.J.A., & van SteegH. (1997). Spontaneous liver tumours and benzo[a]pyrene-induced lymphomas in XPA-deficient mice.Molecular Carcinogenesis19, 46–53.
28.
Anon. (1997). Report on the Current Status of Harmonisation, Fourth International Conference on Harmonisation, 18 pp. Belgium: ICH.
29.
RonchiE. (1996). Advances in Transplantation Biotechnology: Animal to Human Organ Transplants, Xenotransplantation, OECD/GD 96/167, 28 pp. Paris: OECD.
30.
HoudebineL.M. (1994). Production of pharmaceutical proteins from transgenic animals.Journal of Biotechnology34, 269–287.
31.
WallR.J. (1996). Transgenic livestock: progress and prospects for the future.Theriogenology45, 57–68.
32.
WallR.J. (1996). Modification of milk composition in transgenic animals. In Biotechnology's Role in the Genetic Improvement of Farm Animals (ed. MillerR.H., PursellV.G., NormanH.D.), pp. 165–188. Savoy, IL, USA: The American Society of Animal Science.
33.
SharmaA., MartinM.J., OkabeJ.F., TruglioR.A., DhanjalN.K., LoganJ.S., and KhumarR. (1994). An isologous porcine promoter permits high level expression of human hemoglobin in transgenic swine.Bio/Technology12, 55–59.
34.
RosengardA.M., CaryN.R.B., LangfordG.A., TuckerA.W., WallworkJ., and WhiteD.J.G. (1995). Tissue expression of human complement inhibitor decay-accelerating factor in transgenic pigs.Transplantation59, 1325–1333.
35.
PurselV.G., and RexroadC.E. (1993). Status of research with transgenic farm animals.Journal of Animal Science71, Suppl. 3, 10–19.
PowellB.C., WalkerS.K., BawdenC.S., SivaprasadA.V., and RogersG.E. (1994). Transgenic sheep and wool growth: possibilities and current status.Reproduction, Fertility and Development6, 615–623.
38.
DamakS., SuH.Y., JayN.P., and BullockD.W. (1996). Improved wool production in transgenic sheep expressing insulin-like growth factor 1.Bio/Technology14, 185–188.
39.
MüllerM., and BremG. (1996). Intracellular, genetic or congenital immunisation: transgenic approaches to increase disease resistance of farm animals.Journal of Biotechnology44, 233–242.
40.
van ReenenC.G., and BlockhuisH.J. (1993). Investigating welfare of dairy calves involved in genetic modification: problems and perspectives.Livestock Production Science36, 81–90.
41.
van ReenenC.G., and BlockhuisH.J. (1997). Evaluation of welfare of transgenic farm animals: lessons from a case study in cattle.Journal of the Royal Swedish Academy of Agriculture and Forestry136, 99–105.
42.
WalkerS.K., HartwichK.M., and SeamarkR.F. (1996). The production of unusually large offspring following embryo manipulation: concepts and challenges.Theriogenology45, 111–120.
43.
KruipT.A.M., & den DaasJ.H.G. (1997). In vitro produced and cloned embryos: effects on pregnancy, parturition and offspring.Theriogenology47, 43–52.
44.
CansecoR.S., SparkA.E.T., PageR.L., RussellC.G., JohnsonJ.L., VelanderW.H., PearsonR.E., DrohanW.N., and GwazdauskasF.C. (1994). Gene transfer efficiency during gestation and influence of co-transfer of non-manipulated embryos in production of transgenic mice.Transgenic Research3, 20–25.
45.
PageR.L., CansecoR.S., RussellC.G., JohnsonJ.L., VelanderW.H., and GwazdauskasF.C. (1995). Transgene detection during early murine embryonic development after pronuclear microinjection.Transgenic Research4, 12–17.
46.
GordonJ.W. (1989). Transgenic animals.International Reviews of Cytology115, 171–229.
47.
PurselV.G., PinkertC.A., MillerK.F., BoltD.J., CampbellR.G., PalmiterR.D., BrinsterR.D., and HammerR.E. (1989). Genetic engineering of livestock.Science254, 1281–1288.
48.
StrohmanR. (1994). Epigenesis: the missing beat of biotechnology.Bio/Technology12, 156–164.
49.
SippelA.E., SaueressigH., HublerM.C., FaustN., and BoniferC. (1997). Insulation of transgenes from chromosomal position effects. In Transgenic Animals: Generation and Use (ed. HoudebineL.M.), pp. 257–266. Amsterdam: Harwood Academic Publishers.
50.
ShockettP.E., and SchatzD.G. (1996). Diverse strategies for tetracycline-regulated inducible gene expression.Proceedings of the National Academy of Sciences, USA93, 5173–5176.
51.
VivilleS. (1997). Mouse genetic manipulation via homologous recombination. In Transgenic Animals: Generation and Use (ed. HoudebineL.M.), pp. 307–322. Amsterdam: Harwood Academic Publishers.
52.
Anon. (1996). Animal-to-Human Transplants: The Ethics of Xenotransplantation, 146 pp. London: Nuffield Council.
53.
WolfE. (1997). Transgenic animals: an alternative? Proponent's statement. In Developments in Animal and Veterinary Sciences, Vol. 27, Animal Alternatives, Welfare and Ethics (ed. van ZutphenL.F.M., & BallsM.), pp. 261–265. Amsterdam: Elsevier.
54.
FakamizuA., and MurakamiK. (1997). Activated and inactivated renin-angiotensin system in transgenic animals: from gene to blood pressure.Laboratory Animal Science47, 127–130.
55.
LederA., KuoA., CardiffR.D., SinnE., and LederP. (1990). v-H-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid.Proceedings of the National Academy of Sciences, USA87, 9178–9182.
56.
MassoudM., AttalJ., ThépotD., PointuH., StinnakreM.G., ThéronM.C., LopezC., and HoudebineL.M. (1996). The deleterious effects of human erythropoietin gene driven by the rabbit whey acidic protein gene promoter in transgenic rabbits.Reproduction, Nutrition and Development36, 555–563.
57.
WallR.J., RexroadC.E., PowellA., ShamayA., McKnightR., and HennighausenL. (1996). Synthesis and secretion of the mouse whey acidic protein in transgenic sheep.Transgenic Research5, 67–72.
58.
DevinoyE., StinnakreM.G., LavialleF., ThépotD., & Ollivier-BousquetM. (1995). Intracellular routing and release of caseins and growth hormone produced into milk from transgenic mice.Experimental Cell Research221, 272–280.
59.
ShamayA., PurselV.G., WilkinsonF., WallR.J., and HennighausenL. (1992). Expression of the whey acidic protein in transgenic pigs impairs mammary development.Transgenic Research1, 124–132.
60.
CrittendenL.B., and SalterD.W. (1992). A transgene, alv 6, that expresses the envelope of subgroup a avian leukosis virus reduces the rate of congenital transmission of a field strain of avian leukosis virus.Poultry Science71, 799–806.
61.
GavoraJ.S., BenkelB., SpencerJ.L., GagnonC., and CrittendenL.B. (1995). Influence of the alv 6 recombinant avian leukosis virus transgene on production traits and infection with avian tumor viruses in chickens.Poultry Science74, 852–863.
62.
BroomD.M., and JohnsonKG. (1993). Stress and Animal Welfare, 211 pp. London: Chapman and Hall.
63.
HughesB.O., HughesG.S., WaddingtonD., and ApplebyM.C. (1996). Behavioural comparison of transgenic and control sheep: movement order, behaviours on pasture and in covered pens.Animal Science63, 91–101.
64.
Anon. (1993). Biotechnology and genetic engineering: what Europeans think about it in 1993.Eurobarometer39, 1.
65.
van der MeerM., & van ZutphenL.F.M. (1997). Use of transgenic animals and welfare implications. In Welfare Aspects of Transgenic Animals (ed. van Zutphenv, & van der MeerM.), pp. 78–89. Berlin: Springer Verlag.
66.
RollinB. (1986). On telos and genetic manipulation.Between the Species2, 88–89.
67.
VerhoogH. (1992). The concept of intrinsic value and transgenic animals.Journal of Agricultural and Environmental Ethics5, 147–160.
68.
VerhoogH. (1996). Genetic modification of animals: should science and ethics be integrated?The Monist79, 247–263.
69.
VorstenboschJ. (1993). The concept of integrity.Livestock Production Science36, 109–112.
70.
DonnelleyS., McCarthyC.R., and SingletonR. (1994). The brave new world of animal biotechnology.Hastings Centre Report24, Suppl., 31 pp.
71.
O'RiordanT., and JordanA. (1995). The precautionary principle in contemporary environmental politics.Environmental Values4, 191–212.
72.
MephamT.B., MooreC.J., and CrillyR.E. (1996). An ethical analysis of the use of xenografts in human transplant surgery.Bulletin of Medical Ethics116, 13–18.
73.
KockelkorenP.J.H. (1993). Ethical Aspects of Plant Biotechnology, 45 pp. The Netherlands: Ministry of Agriculture, Nature Management and Fisheries, Department of Science and Technology.
74.
SmithJ.A., and BoydK.M. (1991). Lives in the Balance: The Ethics of Using Animals in Biomedical Research, 352 pp. Oxford: Oxford University Press.
75.
PorterD.G. (1992). Ethical scores for animal experiments.Nature356, 101–102.
76.
de Cock BuningT., and TheuneE.P. (1994). A comparison of three models for ethical evaluation of proposed animal experiments.Animal Welfare3, 107–128.
77.
WhiteheadR.H., and JosephJ.L. (1994). Derivation of conditionally immortalized cell lines containing Min mutation from the normal colonic mucosa and other tissue of an ‘Immortomouse'/Min hybrid.Epithelial Cell Biology3, 119–125.
78.
DickinsonP., DorinJ.R., and PorteousD.J. (1995). Modelling cystic fibrosis in the mouse.Moledular Medicine Today1, 140–148.
79.
WolfE., KahntE., EhrleinJ., HermannsW., BremG., and WankeR. (1993). Effects of long-term elevated serum levels of growth hormone on life expectancy of mice: lessons from transgenic animal models.Mechanisms of Ageing and Development68, 71–87.
80.
MephamT.B. (1996). Ethical analysis of food biotechnologies: an evaluative framework. In Food Ethics (ed. MephamT.B.), pp. 101–119. London: Routledge.
81.
BeauchampT.L., and ChildressJ.F. (1994). Principles of Biomedical Ethics, 560 pp. New York: Oxford University Press.